Skip to main content
Log in

A case of cavernous hemangioma in which malignancy was preoperatively excluded by FDG-PET

  • Case Report
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

A contrast-enhanced mass was revealed by computed tomography and magnetic resonance imaging in the left pelvic cavity of a 71-year-old man. Although the mass appeared to be a cavernous hemangioma, malignancy could not be ruled out. Abdominal angiography was performed but failed to rule out malignancy because it revealed vascular dislocation and encasement. 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) was then performed, and suggested a benign tumor, with a standardized uptake value (SUV) of 1.7. Following this finding, because the tumor was large and rupture could not be ruled out, we decided to perform surgery. The resected tumor was a benign cavernous hemangioma, consistent with the result obtained by FDG-PET.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hatayama K, Watanabe H, Ahmed AR, Yanagawa T, Shinozaki T, Oriuchi N, et al. Evaluation of hemangioma by positron emission tomography: role in a multimodality approach. J Comput Assist Tomogr 2003;27:70–77.

    Article  PubMed  Google Scholar 

  2. Hawnaur JM, Whitehouse RW, Jenkins JP, Isherwood I. Musculoskeletal haemangiomas: comparison of MRI with CT. Skeletal Radiol 1990;19:251–258.

    PubMed  CAS  Google Scholar 

  3. Goldberg MA, Lee MJ, Fischman AJ, Mueller PR, Alpert NM, Thrall JH. Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging. Radiographics 1993;13:1047–1062.

    PubMed  CAS  Google Scholar 

  4. Lindholm P, Leskinen-Kallio S, Grenman R, Lehikoinen P, Nagren K, Teras M, et al. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and [11C]methionine. Int J Radiat Oncol Biol Phys 1995;32:787–794.

    PubMed  CAS  Google Scholar 

  5. Kubota K, Yamada S, Ishiwata K, Ito M, Fujiwara T, Fukuda H, et al. Evaluation of the treatment response of lung cancer with positron emission tomography and L-[methyl-11C]methionine: a preliminary study. Eur J Nucl Med 1993;20:495–501.

    Article  PubMed  CAS  Google Scholar 

  6. Terhaard CH, Bongers V, van Rijk PP, Hordijk GJ. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 2001;23:933–941.

    Article  PubMed  CAS  Google Scholar 

  7. Urakami T, Kondo K, Kasugai T, Sakakibara K, Nishiwaki M. A case of recurrent esophageal cavernous hemangioma increasing rapidly after surgery. Jpn J Thorac Cardiovasc Surg 1998;46:1206–1210.

    PubMed  CAS  Google Scholar 

  8. Levine E, Wetzel LH, Neff JR. MR imaging and CT of extrahepatic cavernous hemangiomas. AJR Am J Roentgenol 1986;147:1299–1304.

    PubMed  CAS  Google Scholar 

  9. Wetzel LH, Levine E. Soft-tissue tumors of the foot: value of MR imaging for specific diagnosis. AJR Am J Roentgenol 1990;155:1025–1030.

    PubMed  CAS  Google Scholar 

  10. Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 1992;185:581–586.

    PubMed  CAS  Google Scholar 

  11. Levin DC, Gordon DH, McSweeney J. Arteriography of peripheral hemangiomas. Radiology 1976;121:625–630.

    PubMed  CAS  Google Scholar 

  12. Mansour JC, Schwartz L, Pandit-Taskar N, D’Angelica M, Fong Y, Larson SM, et al. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. J Gastrointest Surg 2006;10:1354–1360.

    Article  PubMed  Google Scholar 

  13. Feldman F, van Heertum R, Manos C. 18FDG-PET scanning of benign and malignant musculoskeletal lesions. Skeletal Radiol 2003;32:201–208.

    PubMed  Google Scholar 

  14. Aoki J, Watanabe H, Shinozaki T, Takagishi K, Tokunaga M, Koyama Y, et al. FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses. Skeletal Radiol 2003;32:133–138.

    PubMed  CAS  Google Scholar 

  15. Mergo PJ, Ros PR. Benign lesions of the liver. Radiol Clin North Am 1998;36:319–331.

    Article  PubMed  CAS  Google Scholar 

  16. Ericson K, von Holst H, Mosskin M, Bergstrom M, Lindqvist M, Noren G, et al. Positron emission tomography of cavernous haemangiomas of the brain. Acta Radiol Diagn (Stockh) 1986;27:379–383.

    CAS  Google Scholar 

  17. Hara M, Lida A, Tohyama J, Miura N, Shiraki N, Itoh M, et al. FDG-PET findings in sclerosing hemangioma of the lung: a case report. Radiat Med 2001;19:215–218.

    PubMed  CAS  Google Scholar 

  18. Hirai K, Umesaki N, Sumi T, Ishiko O, Kanaoka Y, Ogita S, et al. Combined diagnostic imaging for retroperitoneal schwannoma. Oncol Rep 2001;8:773–775.

    PubMed  CAS  Google Scholar 

  19. Hamada K, Ueda T, Higuchi I, Inoue A, Tamai N, Myoi A, et al. Peripheral nerve schwannoma: two cases exhibiting increased FDG uptake in early and delayed PET imaging. Skeletal Radiol 2005;34:52–57.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shigeaki Higashiyama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Higashiyama, S., Kawabe, J., Hayashi, T. et al. A case of cavernous hemangioma in which malignancy was preoperatively excluded by FDG-PET. Ann Nucl Med 22, 327–330 (2008). https://doi.org/10.1007/s12149-007-0101-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-007-0101-4

Keywords

Navigation